Zoetis
ZTS
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Business Wire • 1 day ago • ZTS
Zoetis Announces Pricing of $1.75 Billion Convertible Senior Notes Offering
Business Wire • 2 days ago • ZTS
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
Seeking Alpha • 2 days ago • ZTS
Gabelli Pet Parents' Fund Q3 2025 Contributors And Detractors
Business Wire • 6 days ago • ZTS
Zoetis Declares First Quarter 2026 Dividend; Board Approves 6% Payment Increase
Seeking Alpha • 8 days ago • ZTS
Top 50 High-Quality Dividend Growth Stocks For December 2025
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.